B+
Bull case
20%
Probability
Target price
$2.70
Analysis reference price unavailable
Analysis 2026-09-30 · RankAlpha Sentiment Codex
AIRS
AirsculptDNasdaq / Health Care Equipment & Services
Last Price
Quote time unavailable
Current thesis
Two consecutive quarters of 1% same-center case growth, a broader procedure offering, and lower gross debt support a possible recovery if those improvements translate into sales and margins [#SEC-8K-2026-08-10].
Posture
Defensive
Lead driver
Value
What changed
Next scheduled catalyst: earnings 2026-11-05 · BMO.
What can break
Gross debt of approximately $44.2 million remains relevant despite the reported reduction; cash was $18.8 million at June 30 [#SEC-8K-2026-08-10].
Momentum
17
Value
53
Sentiment
47
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $1.55 · Bull $2.70 · Bear $0.85Analysis 2026-09-30; returns require an exact persisted reference.
Earnings
2026-11-05 · BMO
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-29 • Vendor: Data Vendor v1
Scores
As of 2026-10-29 • Model: HYBRID_IC_RP
AI Memo
As of 2026-09-30 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-10-29
Investment thesis
As of 2026-10-29
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-29. Definitions
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $4.67
Why
Momentum17 · Δ7d -57.6
Value53 · Δ7d -1.9
Sentiment47 · Δ7d +8.8
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Confirming evidence
- • Next scheduled catalyst: earnings 2026-11-05 · BMO.
- • Value remains the lead driver in the composite, 7D delta -1.9.
Contradictions & invalidation
- • Gross debt of approximately $44.2 million remains relevant despite the reported reduction; cash was $18.8 million at June 30 [#SEC-8K-2026-08-10].
- • June sales moderation may persist in a discretionary, consumer-funded procedure business [#PR-EARNINGS-2026-08-17].
- • Second-quarter revenue and adjusted EBITDA declined year over year, and management reduced its full-year EBITDA outlook.
Catalyst clock
2026-11-05 · BMO
Execution against reduced 2026 EBITDA outlook
Lead driver: Value · See fundamentals
Momentum
17
8% active weight
Current posture
7d trendSoftening
Δ7d
-57.6
Δ21d
-
Value
53
47% active weight
Current posture
7d trendSoftening
Δ7d
-1.9
Δ21d
+0.5
Sentiment
47
45% active weight
Current posture
7d trendImproving
Δ7d
+8.8
Δ21d
-
Why this grade
Composite grade D. Momentum 17.5 / Value 52.8 / Sentiment 46.5
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-09-30. Scenario method
Most likely
B
Base case
45%
Probability
Target price
$1.55
Analysis reference price unavailable
Analysis 2026-09-30 · RankAlpha Sentiment Codex
B-
Bear case
35%
Probability
Target price
$0.85
Analysis reference price unavailable
Analysis 2026-09-30 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-10-29
Fundamentals (TTM)
As of 2026-10-29
Market Cap
$120.4M
Beta
2.68
Shares Out
72.1M
P/E (TTM) · Derived
-8.7
P/S (TTM)
0.79
P/FCF (TTM)
55.77
Rev YoY
-2.5%
EPS YoY
+58.6%
Gross Margin
+51.6%
Op Margin
-0.7%
Net Debt
$77.11M
Current Ratio
0.79
As of 2026-10-29 • Updated nightlySource: Internal modelMethods & Data